Evidence map›Paper›PMID 35873101›Full record

ArticleAmerican journal of blood research2022

Serum albumin and ferritin levels: a practical indicator of prognosis in acute myeloid leukemia over 50 years of age?

Osman Yokus, Erdem Sunger, Tahir Alper Cinli, Hasan Goze, Istemi Serin

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of blood research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Osman YokusUniversity of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology Istanbul, Turkey.
Erdem SungerUniversity of Health Sciences, Bagcilar Training and Research Hospital, Department of Internal Medicine Istanbul, Turkey.
Tahir Alper CinliUniversity of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology Istanbul, Turkey.
Hasan GozeUniversity of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology Istanbul, Turkey.
Istemi SerinUniversity of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology Istanbul, Turkey.
University of Health Science · KHBağcılar Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow albumin and high ferritin levels have negative effects on survival in acute myeloid leukemia (AML). In this study, the aim is to determine the role of these factors on survival in patients over 50 years of age with AML.

methodsEighty patients followed up between January 2014 and July 2019 were included in the study. Patients were categorised into three subgroups: The favorable, intermediate and high-risk groups.

resultsThe overall survival of the favorable group was found to be longer in a statistically significant way.

conclusionIn this study, it has been shown that serum albumin and ferritin values are useful and simple laboratory values to show prognosis in AML over 50 years of age.

Indexed as

albuminAMLferritinprognosis

Identifiers

PMID35873101
PMCPMC9301019
OpenAlexW4288064188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.